|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,569.00 GBX | +2.88% |
|
-1.95% | -23.61% |
| 11/06 | Experian Launches Experian Verify for Research Verification | CI |
| 11/06 | LSEG slowly sheds 'AI risk' tag with drive to show growth | RE |
| Fiscal Period: March | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 8.76 | 8.69 | 9.65 | 9.54 | 9.7 | |||||
Return on Total Capital | 11.72 | 11.55 | 12.59 | 12.17 | 12.32 | |||||
Return On Equity % | 32.3 | 19.4 | 27.87 | 23.98 | 28.26 | |||||
Return on Common Equity | 32.6 | 19.5 | 28 | 24.07 | 28.34 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 39.5 | 39.73 | 40.82 | 41.61 | 42.01 | |||||
EBITDA Margin % | 28.96 | 28.22 | 29.77 | 30 | 30.08 | |||||
EBITA Margin % | 27.85 | 27.28 | 28.97 | 29.28 | 29.4 | |||||
EBIT Margin % | 23.36 | 22.84 | 24.55 | 24.95 | 24.96 | |||||
Income From Continuing Operations Margin % | 18.3 | 11.68 | 16.95 | 15.55 | 17.86 | |||||
Net Income Margin % | 18.53 | 11.63 | 16.89 | 15.5 | 17.79 | |||||
Net Avail. For Common Margin % | 18.27 | 11.63 | 16.89 | 15.5 | 17.79 | |||||
Normalized Net Income Margin | 14.87 | 13.33 | 13.97 | 13.46 | 14.78 | |||||
Levered Free Cash Flow Margin | 17.02 | 18.21 | 14.45 | 18.24 | 10.79 | |||||
Unlevered Free Cash Flow Margin | 17.77 | 19.44 | 16.12 | 19.79 | 12.4 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.6 | 0.61 | 0.63 | 0.61 | 0.62 | |||||
Fixed Assets Turnover | 14.23 | 16.61 | 18.65 | 20.64 | 24.59 | |||||
Receivables Turnover (Average Receivables) | 4.84 | 4.53 | 4.48 | 4.53 | 4.25 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.85 | 0.78 | 0.7 | 0.71 | 0.85 | |||||
Quick Ratio | 0.83 | 0.77 | 0.7 | 0.71 | 0.85 | |||||
Operating Cash Flow to Current Liabilities | 0.91 | 0.74 | 0.59 | 0.67 | 0.7 | |||||
Days Sales Outstanding (Average Receivables) | 75.37 | 80.51 | 81.66 | 80.66 | 85.97 | |||||
Average Days Payable Outstanding | 16.17 | 18.89 | 26.32 | 29.04 | 25.34 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 103.17 | 107.44 | 94.22 | 100.53 | 100.32 | |||||
Total Debt / Total Capital | 50.78 | 51.79 | 48.51 | 50.13 | 50.08 | |||||
LT Debt/Equity | 101.72 | 103.51 | 77.25 | 85.32 | 84.2 | |||||
Long-Term Debt / Total Capital | 50.07 | 49.9 | 39.78 | 42.55 | 42.03 | |||||
Total Liabilities / Total Assets | 63.22 | 63.51 | 60.13 | 60.5 | 60.93 | |||||
EBIT / Interest Expense | 19.59 | 11.54 | 9.22 | 10.04 | 9.67 | |||||
EBITDA / Interest Expense | 25.03 | 14.66 | 11.44 | 12.3 | 11.85 | |||||
(EBITDA - Capex) / Interest Expense | 24.19 | 14.17 | 11.23 | 12.04 | 11.62 | |||||
Total Debt / EBITDA | 2.2 | 2.22 | 2.03 | 2.22 | 2.17 | |||||
Net Debt / EBITDA | 2.11 | 2.11 | 1.89 | 2.05 | 2.04 | |||||
Total Debt / (EBITDA - Capex) | 2.28 | 2.29 | 2.07 | 2.27 | 2.21 | |||||
Net Debt / (EBITDA - Capex) | 2.18 | 2.18 | 1.92 | 2.1 | 2.08 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 17.05 | 5.26 | 7.22 | 6 | 12.26 | |||||
Gross Profit, 1 Yr. Growth % | 16.62 | 5.88 | 10.15 | 8.04 | 13.35 | |||||
EBITDA, 1 Yr. Growth % | 15.77 | 5.12 | 9.54 | 6.81 | 12.54 | |||||
EBITA, 1 Yr. Growth % | 16.66 | 5.8 | 10.12 | 7.15 | 12.71 | |||||
EBIT, 1 Yr. Growth % | 18.09 | 6.11 | 10.74 | 7.75 | 12.31 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 43.52 | -32.84 | 55.63 | -2.74 | 28.89 | |||||
Net Income, 1 Yr. Growth % | 45.08 | -33.91 | 55.71 | -2.75 | 28.82 | |||||
Normalized Net Income, 1 Yr. Growth % | 31.37 | -2.73 | 7.48 | 2.08 | 23.26 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 42.47 | -33.01 | 55.74 | -2.84 | 29.17 | |||||
Accounts Receivable, 1 Yr. Growth % | 17.87 | 7.83 | 9.04 | 1.27 | 37.78 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -11.51 | -7.95 | -0.79 | -7.65 | -3.71 | |||||
Total Assets, 1 Yr. Growth % | 8.17 | -0.28 | 7.81 | 10.02 | 10.9 | |||||
Tangible Book Value, 1 Yr. Growth % | -3.96 | -1.18 | -4.32 | 18.33 | 7.61 | |||||
Common Equity, 1 Yr. Growth % | 28.82 | -1.01 | 17.94 | 9.06 | 9.72 | |||||
Cash From Operations, 1 Yr. Growth % | 20.77 | -4.45 | 1.75 | 14.77 | 11.67 | |||||
Capital Expenditures, 1 Yr. Growth % | 31.25 | 1.59 | -37.5 | 20 | 2.08 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 20.12 | 18.63 | -18.93 | 33.8 | -33.59 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 14.17 | 18.11 | -13.69 | 30.2 | -29.66 | |||||
Dividend Per Share, 1 Yr. Growth % | 10.11 | 5.8 | 6.85 | 6.84 | 10.8 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 10.19 | 11 | 6.24 | 6.61 | 9.08 | |||||
Gross Profit, 2 Yr. CAGR % | 6.65 | 11.12 | 7.99 | 9.09 | 10.67 | |||||
EBITDA, 2 Yr. CAGR % | 7.42 | 8.97 | 9.04 | 8.17 | 9.64 | |||||
EBITA, 2 Yr. CAGR % | 7.83 | 9.69 | 9.75 | 8.63 | 9.89 | |||||
EBIT, 2 Yr. CAGR % | 8.19 | 10.25 | 10.56 | 9.24 | 10 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 30.2 | -1.82 | 2.23 | 23.03 | 11.96 | |||||
Net Income, 2 Yr. CAGR % | 31.37 | -2.08 | 1.45 | 23.06 | 11.92 | |||||
Normalized Net Income, 2 Yr. CAGR % | 21.77 | 11.37 | 4.54 | 4.74 | 12.17 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 29.52 | -2.31 | 2.14 | 23.01 | 12.03 | |||||
Accounts Receivable, 2 Yr. CAGR % | 14.38 | 12.74 | 8.43 | 5.09 | 18.12 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -9.08 | -9.75 | -4.44 | -4.28 | -5.7 | |||||
Total Assets, 2 Yr. CAGR % | 10.64 | 3.86 | 3.69 | 8.91 | 10.46 | |||||
Tangible Book Value, 2 Yr. CAGR % | 1.69 | -2.58 | -2.76 | 6.4 | 12.84 | |||||
Common Equity, 2 Yr. CAGR % | 32.08 | 12.93 | 8.05 | 13.42 | 9.39 | |||||
Cash From Operations, 2 Yr. CAGR % | 19.61 | 7.42 | -1.4 | 8.06 | 13.21 | |||||
Capital Expenditures, 2 Yr. CAGR % | -13.4 | 15.47 | -20.32 | -13.4 | 10.68 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 25.11 | 16.3 | 0.48 | 4.15 | -5.74 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 20.11 | 14.69 | 2.45 | 6.01 | -4.3 | |||||
Dividend Per Share, 2 Yr. CAGR % | 4.93 | 7.93 | 6.32 | 6.84 | 8.8 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 8.96 | 8.52 | 9.73 | 6.16 | 8.46 | |||||
Gross Profit, 3 Yr. CAGR % | 6.11 | 6.39 | 10.8 | 8.01 | 10.5 | |||||
EBITDA, 3 Yr. CAGR % | 6.54 | 5.78 | 10.34 | 8.3 | 9.61 | |||||
EBITA, 3 Yr. CAGR % | 6.74 | 6.24 | 11.06 | 8.87 | 9.97 | |||||
EBIT, 3 Yr. CAGR % | 7.06 | 6.41 | 11.88 | 9.62 | 10.25 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 17.97 | 4.42 | 14.47 | 0.55 | 24.95 | |||||
Net Income, 3 Yr. CAGR % | 18.79 | 4.49 | 14.3 | 0.03 | 24.95 | |||||
Normalized Net Income, 3 Yr. CAGR % | 15.04 | 11.87 | 11.69 | 3.71 | 10.59 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 17.98 | 3.96 | 14.12 | 0.45 | 25.03 | |||||
Accounts Receivable, 3 Yr. CAGR % | 10.13 | 12.15 | 11.49 | 5.99 | 15.01 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 7.61 | -8.7 | -6.86 | -5.52 | -4.09 | |||||
Total Assets, 3 Yr. CAGR % | 10.44 | 6.88 | 5.16 | 5.76 | 9.57 | |||||
Tangible Book Value, 3 Yr. CAGR % | 6.27 | 0.72 | -3.16 | 3.81 | 6.8 | |||||
Common Equity, 3 Yr. CAGR % | 16.97 | 19.98 | 14.57 | 8.39 | 12.17 | |||||
Cash From Operations, 3 Yr. CAGR % | 13.13 | 10.98 | 5.49 | 3.72 | 9.25 | |||||
Capital Expenditures, 3 Yr. CAGR % | -11.54 | -8.67 | -5.9 | -8.67 | -8.52 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 10.71 | 20.79 | 4.8 | 10.54 | -10.36 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 8.77 | 18.45 | 5.34 | 10.97 | -7.54 | |||||
Dividend Per Share, 3 Yr. CAGR % | 3.63 | 5.22 | 7.57 | 6.49 | 8.15 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 7.72 | 7.62 | 7.86 | 7.75 | 9.47 | |||||
Gross Profit, 5 Yr. CAGR % | 5.71 | 6 | 6.86 | 7.46 | 10.74 | |||||
EBITDA, 5 Yr. CAGR % | 3.73 | 3.62 | 7.01 | 7.42 | 10.06 | |||||
EBITA, 5 Yr. CAGR % | 3.93 | 3.85 | 7.38 | 7.9 | 10.59 | |||||
EBIT, 5 Yr. CAGR % | 6.15 | 6.07 | 7.79 | 8.38 | 11.12 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 7.23 | -1.03 | 11.41 | 11.5 | 13.46 | |||||
Net Income, 5 Yr. CAGR % | 6.11 | -0.33 | 11.52 | 11.55 | 13.34 | |||||
Normalized Net Income, 5 Yr. CAGR % | 6.56 | 6.6 | 10.06 | 9.93 | 11.89 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 7.78 | -1 | 11.37 | 11.2 | 13.28 | |||||
Accounts Receivable, 5 Yr. CAGR % | 19.28 | 6.34 | 9.45 | 9.27 | 14.1 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 4.75 | 2.66 | 2.62 | -6.96 | -6.4 | |||||
Total Assets, 5 Yr. CAGR % | 7.21 | 5.53 | 7.69 | 7.68 | 7.25 | |||||
Tangible Book Value, 5 Yr. CAGR % | 5.36 | 2.29 | 2.56 | 2.96 | 2.95 | |||||
Common Equity, 5 Yr. CAGR % | 8.5 | 9.67 | 13.32 | 17.31 | 12.47 | |||||
Cash From Operations, 5 Yr. CAGR % | 5.81 | 7.57 | 7.08 | 9.81 | 8.52 | |||||
Capital Expenditures, 5 Yr. CAGR % | -4.67 | -2.05 | -15.16 | -10.59 | 0.41 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 17.26 | -2.85 | 5.39 | 14.95 | 0.45 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 16.51 | -2.26 | 5.67 | 13.97 | 1.37 | |||||
Dividend Per Share, 5 Yr. CAGR % | 4.51 | 4.12 | 4.7 | 5.87 | 8.06 |
- Stock Market
- Stocks
- EXPN Stock
- Financials Experian plc
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















